Professors Seok Jin Kim and Won Seog Kim of the Division of Hematology-oncology of SMC conducted the phase 2 investigator-initiated trial (IIT) of the immune checkpoint inhibitor Avelumab, a PD-L1 inhibitor, in patients with relapsed or refractory...
;Heart Vascular Stroke Institute of Samsung Medical Center (SMC) was designated as Asia;s first third-generation artificial heart transplantation center of excellence by the global health-care company Medtronic. As such, the global-level skills of...
To designate a ventricular arrhythmia surgery training center, Johnson ; Johnson Medical Devices Companies (JJMDC) selects qualified specialists and medical institutions with surgical experiences and skills and grants their qualifications.;Under t...
;Samsung Medical Center (SMC) and the Korea Advanced Institute of Science and Technology (KAIST) have signed a comprehensive agreement on health-care and medical research cooperation. At the ceremony, the two parties agreed to conduct research on ...
;The 6-minute walk test (6MWT) is the most commonly used test for the functional exercise evaluation of patients with chronic lung disease because of its simple and easy procedure. However, its usefulness for lung cancer patients who are planning ...
;Samsung Medical Center (SMC) becomes the first to acquire ISO 27701 certification for treatment, medical support, and research in the medical information system field of Korea. Established by the International Organization for Standardization (IS...
The Stroke Center of the Heart Vascular;Stroke Institute SMC scored the top grade and received an overall score of 100 for 8 consecutive years in the acute stroke adequacy evaluation conducted by the Health Insurance Review and Assessment Service ...
Although beta blockers reduce the burden of ischemia in the heart and have antiarrhythmic effects, they can cause side effects, including bradycardia, hypotension, and claudication. Therefore, it is critical to set the appropriate treatment period...
SMC and KT signed an agreement for development of reality healthcare contents. Under the agreement, the two parties will develop a mixed reality (MR) solution for development of cognitive ability and brain and prevention of dementia. In addition, ...
Professor Junho Jang of Division of hematology-oncology at SMC recently published a paper in PLOS Medicine (IF 11.048) on effective of intravenous ferric carboxymaltose in the treatment of anemia, which is commonly found in cancer patients.;Anemia...
Samsung Medical Center (SMC) signed a research cooperation MOU with JW Pharmaceutical for drug development using the health care big data-based platform.;The joint research project aims to develop innovational drugs to establish personalized preci...
Research teams from the Division of Hematology and Oncology and the Samsung Genome Institute of Samsung Medical Center developed a new indicator that predicts the effectiveness of cancer immunotherapies for lung cancer patients. The researchers an...
